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Sleep is a vital physiological behavior in children’s development, and as such it is important
to be able to efficiently and accurately assess whether children display difficulties with sleep
quality and quantity. The Children’s Sleep Habits Questionnaire [CSHQ; (1)] is one of the
most commonly used assessment tools for pediatric sleep. However, this instrument has
never been validated against the gold standard of sleep measurement [i.e., polysomnog-
raphy (PSG)], and studies comparing it to actigraphy are limited. Therefore, the current
study assessed the validity of four subscales of the CSHQ via direct comparison with PSG
and actigraphy for 30 typically developing school-aged children (ages 6–12). No significant
correlations between relevant CSHQ subscales and PSG variables were found. In terms
of the actigraphy variables, only the CSHQ Night Wakings subscale achieved significance.
In addition, sensitivity and specificity analyses revealed consistently low sensitivity and
high specificity. Overall, the CSHQ Sleep Onset Delay, Sleep Duration, Night Wakings, and
Sleep Disordered Breathing subscales showed low construct validity and diagnostic valid-
ity. These results underscore that caution should be taken when using the CSHQ as the
sole screening tool for sleep problems in children.
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INTRODUCTION
Sleep is essential to children’s physical and emotional well-being.
Unfortunately, recent studies show an increasing trend toward
decreased sleep in childhood due in part to progressively later
bedtimes and unchanged wake times (2, 3). School-aged children
have greater sleep needs than adolescents and adults, and typically
require 10–11 h of sleep/night (4). Today, the average child is not
meeting this recommended duration (5, 6), which can have a range
of daytime consequences.
Sleep difficulties, both in terms of the quantity and quality of
sleep, can have a significant impact on children’s daytime function-
ing. Vriend et al. (7) found that poor sleep in typically developing
children was associated with consequences such as increased neg-
ative affect (i.e., higher levels of sadness and anger) and impaired
attention. These same researchers also assessed the effect of con-
trolled manipulations of children’s sleep on daytime functioning
by shortening and lengthening children’s typical sleep duration by
1 h for 4 days (8). Sleep restriction resulted in significant difficul-
ties with emotion regulation, less positive affect, weaker attention,
and lower academic productivity. These findings indicate that even
a small cumulative change in sleep can have significant daytime
consequences.
It is clear from previous research that many facets of children’s
daytime functioning, including emotional health, interpersonal
relationships, and academic performance, are negatively affected
by poor sleep (7–9). These implications are sobering when one
takes into account the vast number of children presently suffering
from sleep difficulties. Sleep problems affect approximately 25%
of all children, with some prevalence estimates reaching upwards
of 40% (10). As such, accurate measurement of sleep is important,
as this allows for assessment of whether or not a child’s sleep needs
are being met.
There are various ways to measure sleep in children, through
the use of methods that range in their degree of objectivity and
subjectivity. Polysomnography (PSG) is considered to be the gold
standard sleep measurement (4), against which other measures
are typically tested [e.g., (11–16)]. Nocturnal PSG involves directly
monitoring a child’s overnight sleep, and typically occurs in a sleep
lab or hospital setting. Electrodes are placed at specific locations
on a child’s scalp, face, neck, chest, and legs, which provide con-
tinuous electrophysiological recordings of brain activation, eye
movements, skeletal muscle activation, and heart rate. In addition,
piezo chest bands, nasal cannulas, and pulse oximeters assess respi-
ratory effort, airflow, and oxygen saturation. These electrophysio-
logical data provide a range of information about sleep, including
how long it took a child to fall asleep, the total time spent asleep,
and how well the child slept overall. In addition, the data provide
information about nocturnal awakenings, limb movements, sleep
architecture (e.g., the amount of time spent in REM and non-REM
sleep), and any sleep-related breathing difficulties (17).
Polysomnography provides very robust, objective data; how-
ever, because this method of assessment requires placement of
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electrodes by a specialist, and usually requires that a child stay
overnight in a sleep lab, there is a degree of inconvenience and
cost associated with this measure (18). In light of this, actigraphy
is becoming an increasingly popular method of assessing sleep in
children. Allowing for sleep measurement within a child’s home
setting, actigraphy is less costly and less invasive than PSG. (How-
ever, it should be noted that the expense is not negligible, as a single
actigraph currently costs upwards of $1,000). An actigraph (com-
monly in the form of a wristwatch-like device) uses an accelerom-
eter to record gross motor activity in order to estimate sleep–wake
cycles. A child remains in their home environment and wears an
actigraph on their non-dominant wrist, usually for a period of days
or weeks. Activity data are collected and stored by the actigraph
until the testing period is complete, at which point the informa-
tion is downloaded and analyzed (17). Actigraphy data provide
information about the length of a child’s sleep, whether they expe-
rienced any awakenings, and how efficient their sleep was overall.
Unlike PSG, actigraphy has a subjective component associated
with it, as sleep diaries are needed in order to determine several
sleep variables. Sleep diaries are daily sleep logs completed by par-
ents (and/or the child), in which various aspects of a child’s sleep
behaviors are recorded. From these sleep diaries, parent- and/or
child-indicated bedtimes and wake times are required to score
actigraphy variables such as the total time spent in bed, and how
long it took the child to fall asleep. Such scoring of actigraphy
data also involves a degree of clinical judgment on the part of
researchers and clinicians, which may lend an additional level of
subjectivity to this measure. Moreover, actigraphy only estimates
sleep based on body movement and does not record brain activ-
ity. As such, actigraphy cannot determine sleep architecture. Other
variables recorded by PSG are also not recorded by actigraphy, such
as respiration, oxygen saturation, and heart rate. While actigraphy
allows for less invasive measurement of children’s sleep, it only
provides an estimate of a limited range of the variables collected
via PSG.
Although objective measures of children’s sleep behavior pro-
duce highly reliable and valid data, the cost, time, and effort
associated with these measures can also make them difficult to
administer on a wide scale (18). Clinicians frequently opt to use
questionnaires instead of PSG and/or actigraphy because of their
time- and cost-effective nature, as well as their relative ease of
administration. While sleep diaries are also a less costly measure,
they are time-consuming to complete, and the results are difficult
to interpret, as there are no norms that exist for comparison. Ques-
tionnaires involve subjective (and typically retrospective) ratings
of a child’s sleep behaviors. A child or parent rates the frequency
of various sleep behaviors, or indicates their agreement with a
number of statements pertaining to the child’s sleep. In complet-
ing the questionnaire, the child or parent is typically instructed
to focus on a specific period of time (e.g., the previous week or
month). In addition to their ease of administration and scoring,
sleep questionnaires have norms for comparative purposes, and as
such are widely used. This widespread use has led many researchers
to assess the validity of sleep questionnaires via comparisons with
objective measures of sleep behavior such as PSG (11, 19, 20),
actigraphy (21–23), or both (12, 13). In general, these results have
been inconsistent.
One of the most commonly used sleep screening questionnaires
for school-aged children is the Children’s Sleep Habits Question-
naire (CSHQ),developed by Owens et al. (1). The CSHQ’s ubiquity
is evidenced by its widespread use in both the research and the
clinical community. At the time of the current study, the CSHQ
has been cited in over 600 published journal articles. Moreover,
in a clinical capacity, it is one of the most common tools used
for assessing sleep problems in children. The CSHQ is a 45-item,
parent-rated questionnaire that assesses the frequency of behaviors
associated with common pediatric sleep difficulties. A retrospec-
tive measure, the CSHQ instructs parents to rate the frequency
with which their child has displayed various sleep behaviors during
the previous week. Ratings are combined to create eight subscales
that relate to common sleep problems in children: Bedtime Resis-
tance, Sleep Onset Delay, Sleep Duration, Sleep Anxiety, Night
Wakings, Parasomnias, Sleep Disordered Breathing, and Daytime
Sleepiness. Finally, all ratings are summed to create a Total Sleep
Disturbances index, for which a score of over 41 has been found
to indicate a pediatric sleep disorder (1).
During the process of developing this scale, Owens et al. (1)
assessed CSHQ ratings for a community sample of 469 school-
aged children and a clinical sample of 154 children previously
diagnosed with pediatric sleep disorders. The clinical sample was
made up of three groups of children who had received a diagno-
sis of either a behavioral sleep disorder, parasomnia (e.g., sleep
walking, night terrors, etc.), or sleep-disordered breathing in a
pediatric sleep clinic. The CSHQ was found to have acceptable
internal consistency of 0.68 and 0.78 for the community and clin-
ical samples, respectively. A second CSHQ was completed by 60
parents in the community sample, and the test–retest reliability of
the subscales ranged from 0.62 to 0.79, which was considered to be
acceptable. Finally, the validity of the CSHQ was investigated by
comparing total scores and subscale scores of the community and
clinical samples. The three groups in the clinical sample had signif-
icantly higher total scores and subscale scores than the community
sample, and this ability of the CSHQ to differentiate between chil-
dren with and without sleep disorders was taken as evidence of
the questionnaire’s validity. The sensitivity and specificity of the
CSHQ were calculated at 0.80 and 0.72, respectively (1).
Despite this support for the reliability and diagnostic valid-
ity of the CSHQ, a gap in the research literature remains. The
construct validity of this measure has never been assessed though
direct comparison against the gold standard in sleep measurement
(i.e., PSG). One recent study compared CSHQ scores to actigraphy
information for 91 typically developing children in an attempt to
measure the correlation of this subjective questionnaire to a more
objective measure of sleep (24). This study confirmed the pres-
ence of several expected associations between the two measures;
however, there were also a number of expected hypotheses that
were not supported. While this study is the only example, to date,
of a comparison between the CSHQ and a more objective sleep
measure, there have been mixed findings on the clinical utility of
actigraphy in its assessment of sleep. While studies by Lichstein
et al. (13) and Vallières and Morin (16) showed support for actig-
raphy as a satisfactory measure of sleep, results from Sivertsen
et al. (15) indicate suboptimal clinical utility. Meltzer et al. (14)
found actigraphy was effective at detecting sleep, but significantly
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overestimated nocturnal awakenings. Furthermore, these same
researchers found poor agreement between two different actigraph
brands, suggesting that this measure is not universally reliable.
Thus, a comparison of the CSHQ to both PSG and actigraphy is
needed. The widespread use of the CSHQ as an assessment tool
further underscores the importance of evaluating its validity as a
measure of children’s sleep.
Building on past validation studies, the current study aimed to
assess the validity of the CSHQ as an assessment tool for childhood
sleep disorders/problems by directly comparing CSHQ scores to
sleep parameters as measured by PSG and actigraphy. As several
subscales cannot be assessed directly by PSG or actigraphy (e.g.,
those that measure anxiety or resistance associated with a child’s
bedtime), only four of the eight subscales were considered for
analysis: Sleep Onset Delay (i.e., the amount of time it takes a child
to fall asleep), Sleep Duration (i.e., the length of time for which
the child sleeps), Night Wakings (i.e., any awakenings the child
experiences after falling asleep), and Sleep Disordered Breathing
(i.e., whether the child has nocturnal breathing difficulties such
as snoring or obstructive sleep apnea). Finally, these four CSHQ
subscales were assessed for sensitivity and specificity of accuracy
in identifying clinically abnormal sleep behavior. The construct
validity and diagnostic validity of these four CSHQ subscales were
explored as follows.
CORRELATION BETWEEN CSHQ SUBSCALE SCORES AND
PSG/ACTIGRAPHY PARAMETERS
Scores from the CSHQ Sleep Onset Delay, Sleep Duration, Night
Wakings, and Sleep Disordered Breathing subscales were com-
pared to applicable sleep parameters as measured by PSG and
actigraphy. Positive correlations were expected for all subscales,
with the exception of Sleep Duration. As higher CSHQ scores
indicate the presence of problem behaviors, a high Sleep Duration
subscale score indicates that a child sleeps too little. As such, scores
for this subscale were expected to be negatively correlated with
actual sleep duration as measured by both PSG and actigraphy.
SENSITIVITY AND SPECIFICITY OF CSHQ DIAGNOSTIC ACCURACY
To assess the sensitivity and specificity (and thereby the diagnostic
validity) of the four previously mentioned CSHQ subscales, clini-
cally significant subscale scores were assessed for each participant.
The participants reaching score cutoffs for each CSHQ subscale
were compared to those participants reaching PSG and actigraphy
cutoffs for related sleep behaviors. This allowed for assessment
of whether the CSHQ Sleep Onset Delay, Sleep Duration, Night
Wakings, and Sleep Disordered Breathing subscales were able to
accurately identify problematic sleep behavior. Based on the over-
all sensitivity and specificity of the CSHQ as reported by Owens
et al. (1), CSHQ subscale scores were expected to accurately iden-
tify 80% of children who reached PSG and actigraphy criteria for
sleep-disturbed behavior in the current study.
MATERIALS AND METHODS
PARTICIPANTS
Participant data were collected from two larger studies carried
out under the direction of Dr. Penny Corkum at Dalhousie
University1. These two studies involved identical participant
inclusion/exclusion criteria and baseline protocols, and as such,
the baseline data from both studies were combined for the current
study. Participants included 30 typically developing school-aged
children, of which 80.0% were boys (n= 24) and 20.0% were
girls (n= 6). Participants ranged in age from 6.2 to 12.1 years,
with a mean age of 8.6 years (SD= 1.7). The sample was pri-
marily Caucasian (93.3%, n= 28), with 6.7% (n= 2) identified
as multi-racial/other. Household income data for all participants
were as follows: $21,000–$30,000 (3.3%, n= 1), $31,000–$40,000
(6.7%, n= 2), $41,000–$50,000 (16.7%, n= 5), $51,000–$60,000
(3.3%, n= 1), $61,000–$70,000 (16.7%, n= 5), and >$71,000
(50.0%, n= 15); missing data (3.3%, n= 1). Each participant’s
socioeconomic status (SES) was determined by selecting the high-
est of their parents’ occupational scores, calculated as per the
Nam-Powers-Boyd scale (25) [M score= 71.2, score range: 39–96;
missing data (n= 1)].
Community recruitment advertisements encouraged interested
parents to contact the study’s project coordinator in order to have
their children participate in a sleep study. Eligibility was assessed by
administering multiple screening questionnaires. Participants met
eligibility requirements if they were between 6 and 12 years of age,
had no cognitive impairment, and had no prior diagnosis of men-
tal health problems. In addition, eligible participants had no sus-
pected major sleep problems, had no chronic medical/neurological
conditions, were never treated with psychotropic medication for
a mental health disorder, and had not traveled across more than
two time zones in the month prior to participation in the study.
PROCEDURE
The current research was approved by the IWK Health Centre
Research Ethics Board, and was performed in accordance with
the Tri-Council Policy Statement for Ethical Conduct of Research
Involving Humans. After parental consent, participants were pro-
vided with actigraphs and daily sleep diaries. Each participant
wore an actigraph, which collected data for a typical week of
home sleep/wake behavior. During the same period of time, par-
ents completed the sleep diaries. Following the actigraphy week,
participants visited a community hospital for an overnight stay
in a child-friendly sleep lab, where continuous PSG recordings
were collected for an entire night’s sleep. At this point, parents
completed the CSHQ and were instructed to base their ratings
on their child’s sleep behavior during the previous week (which
corresponded to the time period for which actigraphy recordings
were collected).
MEASURES
Polysomnography
Sandman® Elite SD 32+ Digital Sleep Recording System (Embla
Systems, Inc.) was used for recording overnight PSG data using a
standard laboratory PSG protocol. PSG recordings were scored by
1The first of these was a previously completed study that compared sleep parame-
ters and daytime functioning of typically developing children to those of children
with attention-deficit/hyperactivity disorder (ADHD) undergoing a stimulant med-
ication trial. The second is an ongoing study that is comparing sleep parameters
and daytime consequences of sleep restriction in typically developing children and
children with ADHD.
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a registered PSG technologist, who was supervised by a physician
specializing in sleep medicine. Data included information col-
lected via central and occipital electroencephalography (EEG; i.e.,
brain activation), left and right electrooculography (EOG; i.e., eye
movements), electromyography (EMG; i.e., skeletal muscle activa-
tion), and electrocardiography (ECG; i.e., heart rate). In addition,
piezo chest bands, nasal cannulas, and finger pulse oximeters
assessed respiratory effort, airflow, and oxygen saturation. Fur-
thermore, continuous audio and video recordings were collected
during the night in order to increase the ability to detect sleep
disturbances (e.g., snoring). The PSG variables included Sleep
Latency (i.e., the number of minutes from lights out to sleep onset),
Total Sleep Time (i.e., the number of minutes spent asleep in bed,
determined as the sum of sleep stages 1 through 4 plus REM sleep),
Wake After Sleep Onset (WASO; i.e., the percentage of time spent
awake between sleep onset and offset), and a Respiratory Distur-
bance Index (RDI; i.e., a measure of disordered breathing during
sleep, such as obstructive sleep apnea).
Actigraphy
Micromini Motionlogger actigraphs (Ambulatory Monitoring
Inc.) were provided to participants for estimation of sleep–wake
cycles in home settings. For each participant, the actigraph was
worn on the wrist of his or her non-dominant hand. The acti-
graphs were initialized and the data were downloaded using
ACTMe Millennium software version 3.47.0.3 (Ambulatory Mon-
itoring Inc.). Actigraph data were collected using zero-crossing
mode in 1-min epochs and were scored using Action-W soft-
ware version 2.6 (Ambulatory Monitoring Inc.). Once down-
loaded, all actigraph data were scored by the same research assis-
tant. The actigraphy variables collected for the current study
included Sleep Latency (i.e., the number of minutes between
lights out and sleep onset, with lights out being indicated by
parent-completed sleep diaries), Sleep Minutes (i.e., the number of
minutes spent asleep while in bed), and WASO (i.e., the percentage
of minutes spent awake between the onset and offset of sleep).
Children’s Sleep Habits Questionnaire (CSHQ)
The CSHQ is a parent-rated questionnaire comprised of 45 items;
33 scored questions, and 7 additional items intended to provide
other relevant information pertaining to sleep behavior (e.g., noc-
turnal body pains) (1). Each scored question is rated on a 3-point
scale as occurring “usually” (i.e., 5–7 times within the past week),
“sometimes” (i.e., 2–4 times within the past week), or “rarely” (i.e.,
never or 1 time within the past week). A number of items on the
questionnaire are reverse-scored, so that higher scores consistently
indicate problem behaviors. Ratings are combined to form eight
subscales: Bedtime Resistance, Sleep Onset Delay, Sleep Dura-
tion, Sleep Anxiety, Night Wakings, Parasomnias, Sleep Disordered
Breathing, and Daytime Sleepiness.
A Total Sleep Disturbances score is calculated as the sum of
all CSHQ scored questions, and can range from 33 to 99. (It is
worth noting that two scored items are counted twice in the calcu-
lation of two different subscales). A Total Sleep Disturbances score
of over 41 indicates a pediatric sleep disorder, as this cutoff has
been shown to accurately identify 80% of children with a clinically
diagnosed sleep disorder (1).
DATA ANALYSES
A power analysis calculation was performed (α= 0.05, β= 0.20)
and determined that observation of moderate effects (i.e.,
r = 0.50) required a sample size of 23 participants, which the
current study exceeded. The sample size of 30 was of a sufficient
size to observe slightly weaker effects (i.e., r = 0.44). Analyses
were conducted in IBM SPSS Statistics (version 21.0.0.0, 2012)
as follows.
Correlation between CSHQ subscale scores and PSG/actigraphy
parameters
To determine how CSHQ subscales related to PSG and actigraphy,
subscale scores were compared to applicable PSG and actigraphy
sleep parameters using Pearson’s correlation analyses. The only
CSHQ subscale that was not compared to actigraphy data was
Sleep Disordered Breathing, as actigraphy is not able to effectively
assess nighttime breathing disturbances.
Sensitivity and specificity of CSHQ diagnostic accuracy
Analyses were performed to determine the sensitivity and speci-
ficity of the CSHQ Sleep Onset Delay, Sleep Duration, Night
Wakings, and Sleep Disordered Breathing subscales. Normative
data developed by Owens et al. (1) were used to determine CSHQ
subscale cutoff scores for the current sample. A clinically signif-
icant score was considered to be one that was >1 SD above the
mean score of the Owens et al. norms (i.e., Sleep Onset Delay
scores above 1.78, Sleep Duration scores above 4.34, Night Wakings
scores above 4.40, and Sleep Disordered Breathing scores above
3.87). For each subscale, participants were separated into CSHQ
sleep-disturbed and CSHQ non-sleep-disturbed groups based on
these cutoffs.
As well, participants were separated into PSG and actig-
raphy sleep-disturbed groups, and PSG and actigraphy non-
sleep-disturbed groups, using normative data presented by
Scholle et al. (26) and Verhulst et al. (27). Clinically significant
PSG/actigraphy cutoffs were derived from age-appropriate sample
means ±1 SD reported by Scholle et al. as follows: Sleep Latency
(45.30 min), Total Sleep Time/Sleep Minutes (450.50 min), and
WASO (10.30%). A clinically significant RDI cutoff of 3.37 was
derived from the Verhulst et al. age-appropriate sample mean +1
SD. For all variables, clinically significant cutoffs were calculated as
1 SD above the mean, with the exception of Total Sleep Time/Sleep
Minutes, for which smaller (rather than larger) values are consid-
ered more problematic. In this case, the clinically significant cutoff
was calculated as 1 SD below the mean.
If a participant was classified as both CSHQ sleep-disturbed
and PSG/actigraphy sleep-disturbed on comparable sleep para-
meters, this was considered as a true positive. If a partici-
pant was classified as CSHQ sleep-disturbed and PSG/actigraphy
non-sleep-disturbed, this was considered as a false positive. A
false negative constituted a classification of CSHQ non-sleep-
disturbed and PSG/actigraphy sleep-disturbed. Finally, a true
negative was considered as a concurrent classification of CSHQ
non-sleep-disturbed and PSG/actigraphy non-sleep-disturbed.
Comparisons were made between the number of true posi-
tives, false positives, false negatives, and true negatives to deter-
mine the sensitivity and specificity of each CSHQ subscale. For
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each subscale, CSHQ sensitivity was calculated as the number
of true positives divided by the total number of PSG/actigraphy
sleep-disturbed participants. Similarly, specificity was calculated
for each subscale as the number of true negatives divided by
the total number of PSG/actigraphy non-sleep-disturbed partici-
pants. A high level of sensitivity would be indicated if the CSHQ
subscale identified a large proportion of PSG/actigraphy sleep-
disturbed participants as sleep-disturbed. A high level of specificity
would be indicated if the CSHQ subscale identified a large pro-
portion of PSG/actigraphy non-sleep-disturbed participants as
non-sleep-disturbed.
RESULTS
Descriptive statistics for all CSHQ, PSG, and actigraphy variables
are included in Tables 1 and 2. Of interest, CSHQ Total Sleep Dis-
turbances scores ranged from 34 to 47 (M = 39.00, SD= 3.59),
with 33.3% of the sample (n= 10) meeting the diagnostic cutoff
score of 41 for a sleep disorder, and 66.7% (n= 20) falling below
this cutoff score. As illustrated in Table 1, the mean CSHQ sub-
scale scores for the current study were almost identical to those
reported for the Owens et al. (1) community sample. These nor-
mative data were used in the current study to separate participants
into CSHQ sleep-disturbed and non-sleep-disturbed groups for
each subscale. Participant subscale scores that were >1 SD above
the Owens et al. means were considered to be clinically signifi-
cant, and were thus used to designate participants to the CSHQ
sleep-disturbed groups.
Clinically significant PSG and actigraphy cutoffs were derived
from age-appropriate community sample means and SD as
reported by Scholle et al. (26) and Verhulst et al. (27). These
community sample data are included in Table 1. Compared to
the sample means reported by Scholle et al., in general the mean
PSG and actigraphy parameters for the current sample indicated
slightly more problematic sleep (i.e., higher Sleep Latency, lower
Total Sleep Time/Sleep Minutes, and higher WASO). RDI values
for the current study were lower than those reported by Verhulst
et al., with all participants attaining the lowest possible score for
this variable.
CORRELATION BETWEEN CSHQ SUBSCALE SCORES AND
PSG/ACTIGRAPHY PARAMETERS
Correlations between all CSHQ, PSG, and actigraphy variables
are included in Table 3. Although one significant correlation was
found between two PSG variables, no significant correlations were
observed between any CSHQ and PSG variables. In contrast to
the PSG sleep parameters, the actigraphy parameters did share a
significant correlation with a CSHQ subscale. Specifically, CSHQ
Night Wakings was negatively correlated with actigraphy Sleep
Minutes, r(28)=−0.42, p= 0.02, and was positively correlated
with actigraphy WASO, r(28)= 0.47,p= 0.008. This indicates that
parent-reported difficulties with children waking up at night were
associated with shorter sleep durations and more night wakings as
observed by actigraphy. As with PSG, there was also a significant
correlation between two actigraphy variables; however, such cor-
relations among variables on the same measure are not discussed
further, as these were not the focus of the current study.
SENSITIVITY AND SPECIFICITY OF CSHQ DIAGNOSTIC ACCURACY
CSHQ Sleep Onset Delay
Table 4 displays sensitivity and specificity data for the four CSHQ
subscales as compared to PSG and actigraphy. Regarding Sleep
Latency, of the four participants who met PSG Sleep Latency
Table 1 | Descriptive statistics for all variables.
Measure Range M SD Skewness Kurtosis
CSHQ
Sleep Onset Delay 1–2 1.23 (1.25)a 0.43 (0.53)a 1.33 −0.26
Sleep Duration 3–6 3.40 (3.41)a 0.77 (0.93)a 2.06 3.90
Night Wakings 3–7 3.50 (3.51)a 1.08 (0.89)a 2.59 6.42
Sleep Disordered Breathing 3–5 3.23 (3.24)a 0.57 (0.63)a 2.43 5.04
Polysomnography
Sleep Latency (min) 3.80–74.40 25.42 (21.8)b 19.76 (23.5)b 1.31 0.99
Total Sleep Time (min) 384.00–599.30 489.55 (512.2)b 55.30 (61.7)b 0.04 −0.52
Wake After Sleep Onset (%) 1.30–32.10 13.40 (5.1)b 7.78 (5.2)b 0.36 −0.51
RDI 0.00–0.00 0.00 (1.98)c 0.00 (1.39)c – –
Actigraphy
Sleep Latency (min) 2.25–81.00 21.64 (21.8)b 17.23 (23.5)b 1.85 4.09
Sleep Minutes (min) 288.40–598.50 503.24 (512.2)b 65.92 (61.7)b −1.40 2.65
Wake After Sleep Onset (%) 0.30–50.00 11.94 (5.1)b 11.22 (5.2)b 1.59 3.25
CSHQ, Children’s Sleep Habits Questionnaire; RDI, Respiratory Disturbance Index.
All values represent raw scores. Possible score ranges for each CSHQ subscale are as follows: Sleep Onset Delay (0–3), Sleep Duration (3–9), Night Wakings (3–9),
and Sleep Disordered Breathing (3–9).
Community sample data from
aOwens et al. (1),
bScholle et al. (26), and
cVerhulst et al. (27) included for comparison.
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Table 2 | Frequency of participants in sleep-disturbed and
non-sleep-disturbed groups.
Measure n %
CSHQ
Sleep Onset Delay
Sleep-disturbed 7 23.3
Non-sleep-disturbed 23 76.7
Sleep Duration
Sleep-disturbed 3 10.0
Non-sleep-disturbed 27 90.0
Night Wakings
Sleep-disturbed 3 10.0
Non-sleep-disturbed 27 90.0
Sleep Disordered Breathing
Sleep-disturbed 5 16.7
Non-sleep-disturbed 25 83.3
PSG
Sleep Latency
Sleep-disturbed 4 13.3
Non-sleep-disturbed 26 86.7
Total Sleep Time
Sleep-disturbed 9 30.0
Non-sleep-disturbed 21 70.0
Wake After Sleep Onset
Sleep-disturbed 18 60.0
Non-sleep-disturbed 12 40.0
RDI
Sleep-disturbed 0 0.0
Non-sleep-disturbed 30 100.0
Actigraphy
Sleep Latency
Sleep-disturbed 2 6.7
Non-sleep-disturbed 28 93.3
Sleep Minutes
Sleep-disturbed 6 20.0
Non-sleep-disturbed 24 80.0
Wake After Sleep Onset
Sleep-disturbed 14 46.7
Non-sleep-disturbed 16 53.3
CSHQ, Children’s Sleep Habits Questionnaire; PSG, polysomnography; RDI,
Respiratory Disturbance Index.
cutoffs for disturbed sleep, CSHQ Sleep Onset Delay scores identi-
fied 50.0% (n= 2) as sleep-disturbed (i.e., a true positive diagno-
sis), and 50.0% (n= 2) as non-sleep-disturbed (i.e., a false negative
diagnosis). Of the 26 participants who met PSG Sleep Latency
criteria for non-disturbed sleep, 19.2% (n= 5) were identified as
CSHQ sleep-disturbed (i.e., a false positive diagnosis), and 80.8%
(n= 21) were identified as CSHQ non-sleep-disturbed (i.e., a true
negative diagnosis). Overall, the CSHQ Sleep Onset Delay subscale
displayed sensitivity of 0.50 and specificity of 0.81 in its diagnostic
accuracy, as compared to PSG Sleep Latency.
Of the two participants who met actigraphy Sleep Latency cut-
offs for disturbed sleep, CSHQ Sleep Onset Delay scores identified
50.0% (n= 1) as sleep-disturbed (i.e., a true positive diagnosis),
and 50.0% (n= 1) as non-sleep-disturbed (i.e., a false nega-
tive diagnosis). Of the 28 participants who met actigraphy Sleep
Latency criteria for non-disturbed sleep, 21.4% (n= 6) were iden-
tified as CSHQ sleep-disturbed (i.e., a false positive diagnosis),
and 78.6% (n= 22) were identified as CSHQ non-sleep-disturbed
(i.e., a true negative diagnosis). The results using actigraphy were
similar to the PSG findings for Sleep Latency, as overall, the CSHQ
Sleep Onset Delay subscale displayed sensitivity of 0.50 and speci-
ficity of 0.79 in its diagnostic accuracy, as compared to actigraphy
Sleep Latency.
CSHQ Sleep Duration
Regarding sensitivity and specificity data for the CSHQ Sleep
Duration subscale as compared to PSG, of the nine participants
deemed sleep-disturbed according to PSG Total Sleep Time cri-
teria, 22.2% (n= 2) were classified as CSHQ sleep-disturbed
(i.e., true positive), and 77.8% (n= 7) were classified as CSHQ
non-sleep-disturbed (i.e., false negative). Of the 21 PSG non-
sleep-disturbed participants, 4.8% (n= 1) were classified as CSHQ
sleep-disturbed (i.e., false positive), and 95.2% (n= 20) were clas-
sified as CSHQ non-sleep-disturbed (i.e., true negative). When
compared to PSG Total Sleep Time, the CSHQ Sleep Duration
subscale showed overall sensitivity of 0.22 and specificity of 0.95.
Of the six participants deemed sleep-disturbed according to
actigraphy Sleep Minutes criteria, 0.0% (n= 0) were classified as
CSHQ sleep-disturbed (i.e., true positive), and 100.0% (n= 6)
were classified as CSHQ non-sleep-disturbed (i.e., false negative).
Of the 24 actigraphy non-sleep-disturbed participants, 12.5%
(n= 3) were classified as CSHQ sleep-disturbed (i.e., false pos-
itive), and 87.5% (n= 21) were classified as CSHQ non-sleep-
disturbed (i.e., true negative). When compared to actigraphy Sleep
Minutes, the CSHQ Sleep Duration subscale showed overall sensi-
tivity of 0.00 and specificity of 0.88. The actigraphy results follow
the same trend as the PSG results when comparing the sleep
duration variables to the CSHQ Sleep Duration subscale.
CSHQ Night Wakings
The CSHQ Night Wakings subscale was compared to PSG WASO
and actigraphy WASO, respectively. According to the PSG WASO
cutoff, 18 participants were classified as sleep-disturbed. Of these,
11.1% (n= 2) received a concurrent classification of CSHQ sleep-
disturbed (i.e., true positive), whereas 88.9% (n= 16) were clas-
sified as CSHQ non-sleep-disturbed (i.e., false negative). Twelve
participants were considered PSG non-sleep-disturbed, of which
8.3% (n= 1) were considered CSHQ sleep-disturbed (i.e., false
positive), and 91.7% (n= 11) were considered CSHQ non-sleep-
disturbed (i.e., true negative). In comparison to PSG WASO, the
CSHQ Night Wakings subscale displayed sensitivity of 0.11 and
specificity of 0.92.
According to the actigraphy WASO cutoff, 14 participants were
classified as sleep-disturbed. Of these, 21.4% (n= 3) received a
concurrent classification of CSHQ sleep-disturbed (i.e., true posi-
tive), whereas 78.6% (n= 11) were classified as CSHQ non-sleep-
disturbed (i.e., false negative). Sixteen participants were consid-
ered actigraphy non-sleep-disturbed, of which 0.0% (n= 0) were
considered CSHQ sleep-disturbed (i.e., false positive), and 100.0%
(n= 16) were considered CSHQ non-sleep-disturbed (i.e., true
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Table 3 | Correlations between CSHQ, PSG, and actigraphy variables.
Variable CSHQ PSG ACT
SOD SD NW SDB SL TST WASO RDI SL SM WASO
CSHQ_SOD 1 0.13 0.26 −0.09 0.31 −0.07 −0.05 a 0.02 −0.11 0.20
CSHQ_SD 1 0.13 0.17 0.13 −0.16 0.09 a 0.33 0.02 −0.10
CSHQ_NW 1 0.31 −0.19 −0.11 0.17 a −0.17 −0.42* 0.47**
CSHQ_SDB 1 −0.24 −0.09 0.11 a 0.06 0.15 −0.04
PSG_SL 1 −0.23 0.11 a 0.16 0.25 −0.32
PSG_TST 1 −0.80** a 0.03 0.28 −0.28
PSG_WASO 1 a 0.05 −0.21 0.24
PSG_RDI a a a a
ACT_SL a 1 0.06 −0.26
ACT_SM a 1 −0.90**
ACT_WASO a 1
CSHQ, Children’s Sleep Habits Questionnaire; CSHQ_SOD, CSHQ Sleep Onset Delay; CSHQ_SD, CSHQ Sleep Duration; CSHQ_NW, CSHQ Night Wakings;
CSHQ_SDB, CSHQ Sleep Disordered Breathing; PSG, polysomnography; PSG_SL, PSG Sleep Latency; PSG_TST, PSG Total Sleep Time; PSG_WASO, PSG Wake
After Sleep Onset; PSG_RDI, PSG Respiratory Disturbance Index; ACT, actigraphy; ACT_SL, ACT Sleep Latency; ACT_SM, ACT Sleep Minutes; ACT_WASO, ACT Wake
After Sleep Onset.
Significant values are shown in boldface. *p< 0.05, **p<0.01.
aCannot be computed because PSG RDI variable is constant.
Table 4 | Sensitivity and specificity of CSHQ subscales as compared to
PSG and actigraphy sleep parameters.
CSHQ subscale Polysomnography Actigraphy
Sensitivity Specificity Sensitivity Specificity
Sleep Onset
Delay
0.50 0.81 0.50 0.79
Sleep Duration 0.22 0.95 0.00 0.88
Night Wakings 0.11 0.92 0.21 1.00
Sleep Disordered
Breathing
Undefined 0.83 a a
CSHQ, Children’s Sleep Habits Questionnaire.
aCannot be computed because breathing disturbances are not measured via
actigraphy.
negative). In comparison to actigraphy WASO, the CSHQ Night
Wakings subscale displayed sensitivity of 0.21 and specificity of
1.00. This trend again, follows similarly to the PSG WASO findings.
CSHQ Sleep Disordered Breathing
Lastly, sensitivity and specificity data for the CSHQ Sleep Disor-
dered Breathing subscale were found as follows: no participants
were classified as sleep-disturbed according to the PSG RDI cut-
off. Of the 30 participants considered PSG non-sleep-disturbed,
16.7% (n= 5) were classified as CSHQ sleep-disturbed (i.e., false
positive), and 83.3% (n= 25) were classified as CSHQ non-sleep-
disturbed (i.e., true negative). Based on these results, the CSHQ
Sleep Disordered Breathing subscale had a specificity of 0.83. Since
there were no PSG sleep-disturbed participants for this subscale, its
sensitivity could not be properly assessed and remains undefined
for the current study.
DISCUSSION
The goal of the present study was to assess the validity of the
CSHQ as a screening tool for children’s problematic sleep behav-
ior. Four CSHQ subscales (i.e., Sleep Onset Delay, Sleep Duration,
Night Wakings, and Sleep Disordered Breathing) were compared
to applicable sleep parameters as measured by PSG and actig-
raphy in order to explore their construct validity. PSG variables
included Sleep Latency, Total Sleep Time, WASO, and RDI, while
actigraphy variables included Sleep Latency, Sleep Minutes, and
WASO. Pearson’s correlation analyses were performed to assess
the construct validity of the CSHQ subscales in relation to similar
PSG and actigraphy variables. Surprisingly, no significant corre-
lations were found between CSHQ subscales and applicable PSG
sleep parameters, and actigraphy parameters only showed signif-
icant correlations with one CSHQ subscale (i.e., Night Wakings).
The diagnostic validity of the CSHQ was explored by assessing the
sensitivity and specificity of each of these four CSHQ subscales
in comparison with identification of problematic sleep behaviors
as determined by the gold standard of sleep assessment, PSG.
These four CSHQ subscales were also compared to actigraphy,
which allowed for an examination of the CSHQ’s ability to identify
problematic sleep as determined by an objective measure of sleep
taken in the home environment. Overall, when compared against
both PSG and actigraphy, the CSHQ subscale scores consistently
displayed low sensitivity and high specificity.
These results imply that higher scores on CSHQ Sleep Onset
Delay, Sleep Duration, Night Wakings, and Sleep Disordered
Breathing subscales do not necessarily align with more problem-
atic sleep parameters as measured by PSG and actigraphy. Instead,
the scarcity of significant correlations suggests that scores on these
subscales share little to no relation with children’s objectively mea-
sured sleep behavior. In this respect, it would appear that the
CSHQ may not be the most valid screening tool for children’s sleep
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problems, as an elevated subscale score may not indicate an actual
problem in the area of assessment, and vice versa. Although sig-
nificant predicted correlations were observed between the CSHQ
Night Wakings subscale and applicable actigraphy variables, these
results must be interpreted cautiously. Actigraphy is not consid-
ered to be a consistently reliable measure of nighttime awakenings,
and Sivertsen et al. (15) concluded that actigraphy’s clinical utility
is suboptimal due to its difficulty in detecting nighttime wake-
fulness. In contrast to this under-detection reported by Sivertsen
et al., Meltzer et al. (14) found that actigraphy significantly over-
estimated nighttime wake minutes. This reported inconsistency
in actigraphy’s ability to accurately detect nighttime wakefulness
might account for the fact that actigraphy WASO (and by associ-
ation, actigraphy Sleep Minutes) were the only sleep parameters
significantly associated with any CSHQ subscale. In this light, one
must be cautious in interpreting the significance between these
actigraphy scores and CSHQ Night Wakings scores. No other actig-
raphy variable was significantly correlated with CSHQ subscales,
which is in line with the mixed results reported by other studies
that have used actigraphy to validate sleep questionnaires [e.g., (12,
23, 24)]. Combined, the current results provide only marginal sup-
port for this study’s first hypothesis, as only one CSHQ subscale
was significantly associated with any related PSG or actigraphy
variables. For the most part, this first hypothesis was unsupported
by the current findings.
Based on the accuracy of the CSHQ as reported by Owens et al.
(1) during its development, as well as the widespread use of this
measure as a screening tool, these results are surprising. Although
the current sample size was relatively small, power analyses indi-
cated it was of sufficient size to observe moderate effects and none
of the correlations with PSG even approached significance. The
fact that no significant relations were found between CSHQ sub-
scale scores and related PSG sleep parameters raises questions of
the CSHQ’s clinical usefulness as the sole screening tool for child-
hood sleep disturbances in the four areas assessed. In order to
support the use of any proxy sleep measure, that questionnaire’s
scores must be closely related to PSG scores, as this is the gold stan-
dard of sleep measurement (4). The lack of significant correlations
indicates that the construct validity of these four CSHQ subscales
is poor.
In addition to the previously discussed correlations, the diag-
nostic sensitivity and specificity of these four CSHQ subscales were
assessed by comparing participants meeting clinically significant
subscale score cutoffs with those meeting clinical cutoffs for related
PSG and actigraphy parameters. The actigraphy data supplement
the PSG data by providing an estimate of the child’s sleep while in
the home environment, as opposed to the sleep lab environment.
Based on data reported by Owens et al. (1) during the develop-
ment of this measure, CSHQ subscales were expected to display
sensitivity of 0.80 and specificity of 0.72. The current results indi-
cate that the CSHQ’s sensitivity is quite low in comparison with
the diagnostic gold standard. This was found for both PSG and
actigraphy, meaning that most of the children who exhibited clin-
ically significant Sleep Latency, Total Sleep Time/Sleep Minutes,
and WASO according to PSG/actigraphy were not recognized as
such by the CSHQ. This is concerning, when one considers the fact
that this questionnaire is used widely to screen for sleep difficulties
in children. If one extends the results of the current study to the
general population, this means that a large proportion of children
with legitimate disordered sleep may show “normal” CSHQ scores
and risk going undiagnosed. Without proper identification and
diagnosis, problem behaviors cannot be effectively treated. If the
CSHQ is being used as the sole diagnostic tool by clinicians, this
raises the possibility of a large number of children missing the
opportunity for treatment with effective sleep interventions.
In contrast to the low sensitivity displayed by the four CSHQ
subscales, the CSHQ displayed a high degree of diagnostic speci-
ficity with both PSG and actigraphy, meaning it had a low rate of
“misdiagnosis,” or false positives. This may be directly related to
the questionnaire’s low sensitivity values; it would seem as though
the CSHQ consistently under-reports problem sleep behaviors,
whether they exist or not. If a questionnaire’s use consistently
results in floor effects, it will neither misdiagnose healthy indi-
viduals nor properly diagnose unhealthy individuals. Therefore,
although the four CSHQ subscales displayed impressive specificity
in the current study, their low sensitivity resulted in low overall
diagnostic accuracy for this measure as a whole. As relatively high
sensitivity and specificity were expected for all subscales, the cur-
rent study’s second hypothesis regarding the diagnostic validity of
the CSHQ was not supported.
The current study has clear clinical implications, in that caution
should be taken when using the CSHQ as the sole screening tool for
a child with possible sleep difficulties. The low sensitivity and high
specificity of these four CSHQ subscales are of limited usefulness
for screening or diagnosing sleep problems. Although the CSHQ
will likely not misdiagnose a child with a sleep disorder if one is
not present, it will likely miss identifying a sleep problem when one
does exist. It is important to note that these results do not negate
the validity of parental perception of sleep problems in children.
In contrast, they suggest that the CSHQ may not be accurately tap-
ping into parent perception, and as such, problem sleep behaviors
are not actually being flagged as problematic by this questionnaire.
While this questionnaire may serve as a useful starting point for
parents and clinicians to broach the subject of a child’s sleep pat-
terns, it seems that its best use would be to complement other more
robust measures of sleep behavior. A multimodal approach may
be required in order to gain a comprehensive understanding of
a child’s sleep, which could include sleep diaries, questionnaires,
actigraphy, parent interview, and PSG where possible and when
appropriate to use.
As with any research undertaking, the current study is not with-
out limitations. First, a larger sample would have had increased
power to detect more subtle effects. The sex distribution of partici-
pants was also uneven due to the nature of the studies that provided
the current data. Despite this unequal sex distribution, studies have
shown that sex differences in sleep do not emerge until puberty
(28) and all of the current participants were pre-pubertal. Exclu-
sion criteria for participants included any previously diagnosed or
suspected sleep disorder, and it is possible that by refining the sam-
ple in this way, potential variability in the data was lost, which may
have altered the pattern of results. Building on the current study,
future research could test the validity of the CSHQ in a more het-
erogeneous population that includes both sleep-disordered and
non-sleep-disordered children. It is also worth noting that PSG
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cutoffs for the current study were based on normative data from
Scholle et al. (26), whose sample consisted of children in Germany.
It is possible that cultural differences exist between typical German
and Canadian patterns of sleep behavior, which would skew the
mean sleep behavior data. However, a relative lack of North Amer-
ican normative data that matched the current sample necessitated
the use of these norms for reference.
A further limitation in the current study design includes the
fact that CSHQ results were based on the week leading up to the
child’s visit to the sleep lab, meaning that these scores did not
technically encompass the child’s sleep on the night of PSG test-
ing. Although all efforts were made at the sleep lab to replicate
typical home sleeping patterns (including bedtimes, wake times,
and other pre-bedtime rituals), the sleep lab does constitute a dif-
ferent environment from that in which the child is typically used to
sleeping. In comparing typically developing children’s first night
in a sleep lab to their usual home sleep, Bessey et al. (29) reported
significantly reduced sleep duration and interestingly, significantly
reduced WASO in the sleep lab setting. This “first night effect”
could have altered children’s sleep for the current study, so that
PSG recordings did not accurately reflect the typical sleep at home
that was the basis for the parent-rated CSHQ scores. However,
the inclusion of the actigraph data mitigates this concern, as these
data were collected in the home environment during the same
week that the CSHQ respondents were basing their ratings on.
Similar comparisons were found between CSHQ and actigraphy
that were also found between CSHQ and PSG, lending support
for the notion that the sleep lab environment may not have been
a major confound within the current research study data.
It is also important to highlight the strengths of the current
study. This study compared subjective and objective measures of
sleep behavior in school-aged children, and represents the first
study to assess one of the most commonly used sleep question-
naires, the CSHQ, against the gold standard of sleep measurement,
PSG. Furthermore, although a larger sample size would have had
more power to detect subtle effects, the current sample of 30 par-
ticipants was of a sufficient size to detect moderate effects. A larger
sample would not necessarily have made for a more meaningful
study, as only moderate or large effect sizes would have actually lent
support for the validity of the CSHQ. In addition, although the
selective exclusion of children with suspected sleep disorders may
mean that the current results apply only to children with typical
sleep, there was nevertheless quite a bit of variance in CSHQ, PSG,
and actigraphy data. Interestingly, 33.3% of the sample had CSHQ
Total Sleep Disturbances scores that exceeded the diagnostic cutoff
score of 41, which is in line with current sleep disorder prevalence
estimates (10). Finally, and most importantly, the current study
brought together parent-rated CSHQ scores and PSG for the first
time in order to assess the construct validity and diagnostic valid-
ity of four of the CSHQ’s eight subscales. As previously discussed,
future research could build on the current study’s design by includ-
ing a larger and more diverse sample of participants, so that the
CSHQ’s validity could be assessed for both typical and disordered
sleepers. Regardless of any potential alterations to the design of
future studies, it is vital that the current research be replicated.
The current findings underscore the importance of not using
the CSHQ as the sole sleep screening tool for children. As
previously mentioned, further research is required to determine
whether these findings are anomalous. The high prevalence of
children not meeting recommended nightly sleep requirements
(5, 6, 10) is made even more ominous by evidence for the negative
impacts of sleep deprivation on children’s cognitive and emotional
well-being (7, 8). Combined, these factors clearly underscore the
serious need for a valid tool in the screening and diagnosis of sleep
problems in children.
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